THTR1 inhibitors are a class of chemical compounds that specifically target the thiamine transporter 1 (THTR1), a membrane protein responsible for the uptake of thiamine (vitamin B1) into cells. Thiamine is an essential nutrient that plays a key role in cellular metabolism, particularly in energy production through its involvement in the enzymatic processes of the citric acid cycle and carbohydrate metabolism. THTR1 is responsible for the active transport of thiamine across the cell membrane, ensuring sufficient intracellular levels of this vitamin for metabolic processes. Inhibitors of THTR1 interfere with the transporter's ability to facilitate the entry of thiamine into cells, disrupting its absorption and availability.
The mechanism of action for THTR1 inhibitors typically involves binding to the transporter's active site or altering its conformation, preventing thiamine from binding and being transported into the cell. By blocking thiamine uptake, these inhibitors lead to reduced intracellular levels of thiamine, which can affect metabolic pathways that depend on this vitamin. THTR1 inhibitors are valuable tools for studying the role of thiamine in cellular metabolism and the specific mechanisms of vitamin transport across cell membranes. Researchers use these inhibitors to investigate how changes in thiamine uptake influence energy production, cell growth, and overall metabolic health. By inhibiting THTR1, scientists can also explore the regulatory mechanisms that control nutrient transport and how disruptions in these pathways impact cellular and systemic energy balance.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
May cause hypomethylation of the SLC19A2 gene promoter, leading to transcriptional silencing and subsequent reduction in THTR1 protein levels. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Could intercalate with DNA strands within the SLC19A2 gene, obstructing RNA polymerase and thus decreasing THTR1 synthesis. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Might act on retinoic acid response elements in the SLC19A2 gene promoter, directly downregulating THTR1 transcription. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
As a dihydrofolate reductase inhibitor, it may lead to a secondary decrease in THTR1 expression by disrupting cellular one-carbon metabolism. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Could cause DNA damage response activation, leading to cell cycle arrest and subsequent decrease in THTR1 expression as part of a global reduction in transcription. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
May reduce the endosomal acidity, potentially leading to a decrease in THTR1 expression due to altered cellular trafficking and processing of the protein. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
By activating nuclear receptors that bind to the SLC19A2 gene's promoter, rifampicin could decrease transcriptional activity, resulting in less THTR1 protein production. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Acts as a histone deacetylase inhibitor, leading to a more condensed chromatin structure around the SLC19A2 gene and reduced transcriptional activity of THTR1. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This catechin could directly inhibit the activity of DNA methyltransferases, leading to hypomethylation and transcriptional repression of the THTR1 gene. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
By inhibiting GSK-3 beta, lithium chloride could dismantle the Wnt signaling pathway, culminating in decreased transcription of THTR1. | ||||||